Wu T - Search Results

1

Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.

Tsai JJ, Wu T, Leung H, Desudchit T, Tiamkao S, Lim KS, Dash A. Tsai JJ, et al. Among authors: wu t. Acta Neurol Scand. 2018 Apr;137(4):378-391. doi: 10.1111/ane.12879. Epub 2017 Dec 7. Acta Neurol Scand. 2018. PMID: 29214650 Review.

2

Preliminary Asian experience of using perampanel in clinical practice.

Chiang HI, Lim SN, Hsieh HY, Cheng MY, Chang CW, Johnny Tseng WE, Li HT, Lin CY, Wu T. Chiang HI, et al. Among authors: wu t. Biomed J. 2017 Dec;40(6):347-354. doi: 10.1016/j.bj.2017.09.003. Epub 2018 Feb 3. Biomed J. 2017. PMID: 29433838 Free PMC article.

3

Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics.

Lin KL, Lin JJ, Chou ML, Hung PC, Hsieh MY, Chou IJ, Lim SN, Wu T, Wang HS. Lin KL, et al. Among authors: wu t. Epilepsy Behav. 2018 Aug;85:188-194. doi: 10.1016/j.yebeh.2018.06.033. Epub 2018 Jul 4. Epilepsy Behav. 2018. PMID: 30032806 Free article. Clinical Trial.

4

Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations.

Nishida T, Lee SK, Wu T, Tiamkao S, Dash A. Nishida T, et al. Among authors: wu t. Epilepsia. 2019 Mar;60 Suppl 1:47-59. doi: 10.1111/epi.14644. Epilepsia. 2019. PMID: 30869168 Clinical Trial.

5

Effectiveness and safety of perampanel in adults with mesial temporal epilepsy: A single-center postmarketing study in Taiwan.

Lin CY, Lim SN, Chiangn HI, Cheng MY, Chang CW, Tseng WJ, Hsieh HY, Li HT, Wu T. Lin CY, et al. Among authors: wu t. Medicine (Baltimore). 2019 Oct;98(42):e17171. doi: 10.1097/MD.0000000000017171. Medicine (Baltimore). 2019. PMID: 31626082 Free PMC article.

6

Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.

Lim SN, Wu T, Tseng WJ, Chiang HI, Cheng MY, Lin WR, Lin CN. Lim SN, et al. Among authors: wu t. J Neurol. 2021 Oct;268(10):3744-3757. doi: 10.1007/s00415-021-10506-9. Epub 2021 Mar 22. J Neurol. 2021. PMID: 33754209 Review.

7

Treatment of pharmacoresistant sleep-related hypermotor epilepsy (SHE) with the selective AMPA receptor antagonist perampanel.

Lim SN, Cheng MY, Hsieh HY, Chiang HI, Wu T. Lim SN, et al. Among authors: wu t. Sleep Med. 2021 May;81:382-386. doi: 10.1016/j.sleep.2020.12.020. Epub 2021 Apr 5. Sleep Med. 2021. PMID: 33831666

8

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.

Villanueva V, D'Souza W, Goji H, Kim DW, Liguori C, McMurray R, Najm I, Santamarina E, Steinhoff BJ, Vlasov P, Wu T, Trinka E; PERMIT pooled analysis participants. Villanueva V, et al. Among authors: wu t. J Neurol. 2022 Apr;269(4):1957-1977. doi: 10.1007/s00415-021-10751-y. Epub 2021 Aug 24. J Neurol. 2022. PMID: 34427754 Free PMC article.

9

Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study.

Wu T, Kim DW, Alsaadi T, Goji H, Kanemoto K, Chinvarun Y, Dash A, Cappucci S, Villanueva V. Wu T, et al. J Neurol Sci. 2024 Nov 15;466:123173. doi: 10.1016/j.jns.2024.123173. Epub 2024 Aug 14. J Neurol Sci. 2024. PMID: 39284274

10

Carbon disulfide induced polyneuropathy: sural nerve pathology, electrophysiology, and clinical correlation.

Chu CC, Huang CC, Chu NS, Wu TN. Chu CC, et al. Among authors: wu tn. Acta Neurol Scand. 1996 Oct;94(4):258-63. doi: 10.1111/j.1600-0404.1996.tb07062.x. Acta Neurol Scand. 1996. PMID: 8937537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,585 results

Search Page

Filters